Article
Green Bay, WI-The recently introduced miniature glaucoma shunt (Ex-Press) is an exciting modality with a lot of potential, but this new IOP-lowering treatment still requires further study to define its long-term efficacy and place in the armamentarium of glaucoma management options, said James E. Memmen, MD.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.